Myconostica Announces Appointment of David Evans as Non-Executive Director

11-Oct-2010 - United Kingdom

Myconostica Ltd announces the immediate appointment of Mr David Evans as independent Non-Executive Director.

As the former CFO of Shield Diagnostics Ltd, David guided the business through its IPO and then, as its CEO, through its merger with Axis Biochemical ASA to form Axis-Shield plc, a Fully Listed diagnostics company. He is currently Chairman or Non-Executive Director of a number of companies within the diagnostic and life science space including Epistem Holdings plc, Immunodiagnostic Systems Holdings plc and Omega Diagnostics Group plc, all AIM listed diagnostic companies. David was Chairman of Manchester-based personalised medicine/ companion diagnostic business DxS Ltd for three years until June 2009 and during this time he steered DxS’s transformation from a reference genetics laboratory to a thriving molecular diagnostics products company.

Other news from the department people

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

See the theme worlds for related content